Box News

This is true, but in a very narrow context. Over a period of 30 years, Australian medical doctor John Holt (now retired) was using a frequency of 434 megahertz (MHz)— or 434 million Hz—as part of an overall treatment to eliminate cancer cells. Peter Walker reports:

Activated cancer cells are vulnerable to low levels (150 rads) of X-ray radiation. . . . [However, under normal circumstances] only a small number of cancer cells are active at any one time, making cancer very difficult to treat [with X-rays]. . . . Holt discovered that by exposing the body to 434 MHz radio waves, all the cancer cells were activated for a short period (about 20 minutes) and could thus be destroyed by subsequent low level X-ray radiation. . . . Over 35,000 patient records stretching back over a period of 30 years . . . [indicate Holt’s] high success rates for treating cancer. . . . Dr. Holt’s work became known to the Rife research groups in 2004 after an Australian television program, “A Current Affair” reported positively about Holt’s work. . . . Yet his work had been largely ignored by cancer research organizations in Australia and elsewhere. . . . Despite several requests for his method to be scientifically validated in proper clinical trials, these requests were largely ignored except for two bogus trials that, according to Dr. John Holt, were not set up to properly validate his methods and were designed to discredit his work. . . . AMA doctors had not even bothered to look at his methods for over 15 years.

After Holt was denied access to X-ray equipment, he developed an alternative method to kill cancerous tumors by injecting them with a glucose blocking agent and then subjecting them to 434 MHz radio waves. All cancer cells require glucose in order to grow; so essentially he was starving them. Using a glucose blocking agent in conjunction with 434 MHz is generally believed to be less effective than X-rays, but it does help in many cases. Incidentally, Dr. Holt believed that the main cancer stimulating frequencies were in the radio wave range of 430 MHz to 440 MHz. However, he then found that frequencies in the microwave range above 2 GHz (gigahertz, or 2 billion Hz) could also cause cancer cells to grow. Many cell phones operate in these ranges. When placed close to the head, these high-frequency cell phones create brain tumors. Keep your phone on “speaker” mode away from your ear or use a specially designed protective earpiece. For vital information about electrosmog and remedies, see the Chapter 1 Insert, “Electromagnetic Fields and Your Health,” pages 11–16.

- Nenah Sylver, The Rife Handbook of Frequency Therapy and Holistic Health, an integrated approach for cancer and other diseases (2011), p.677

For most health problems, frequencies below 20,000 Hz work well. For cancer, frequencies in the KHz (kilohertz, or thousands of Hz) range are more effective than lower numbers. However, some units cannot transmit in those ranges; so if yours can’t, there are still some excellent tumor frequencies in the lower ranges. Peter Walker cites research from German scientist Kurt Olbrich, who acknowledged that frequency therapies eliminate cancer much more successfully than drugs. 

When treating cancer, it is very important to determine the exact frequency to use. Otherwise, the cancer virus will not be destroyed and in some cases may even grow faster. . . . Every person has their own systemic weaknesses and the development stage of cancers differs accordingly, according to the environment in the patient’s body. . . . The frequency to use must be determined individually by testing the virus obtained from each patient under the microscope—just like what Royal Rife did. . . . Most people do not know that viruses do not have a fixed size. They are smaller when young and larger when full size; and this effects their resonance frequency, too.

The body’s terrain does contribute to a pathogen’s oscillation rate. And a customized program is always preferable. However, for many individuals with cancer, the terrain is similar. Rifers have obtained better-than average to excellent results with the frequencies in this Frequency Directory, especially those used by Rife himself. If you don’t have a practitioner to customize a protocol for you, the lists in this Directory are a good place to start.

- Nenah Sylver, The Rife Handbook of Frequency Therapy and Holistic Health, an integrated approach for cancer and other diseases (2011), p.677

The Radiation Used to Treat Cancer—Causes Cancer!

Cancer is usually treated with chemo and radiation “therapy,” dispensed to either a small area or the entire body. We know that chemo consists of poisonous chemicals. But what, exactly, is the “radiation” dispensed as cancer treatment? And how does it work? The radiation administered under medical auspices is ionizing radiation (IR), which can be in the form of X-rays, gamma rays, or radioactive substances including radioactive iodine. Ionizing radiation is acknowledged to kill cancerous cells because it permanently shatters the natural bonds between DNA strands. But IR also destroys the DNA of normal healthy cells. IR, reports B. Blake Levitt, “consists of very short wavelengths . . . which have enough power to knock electrons off their nuclear orbits and therefore can cause permanent damage on the cellular level . . . [including] genetic mutations.” This destabilization of atoms—in other words, the formation of free radicals— corresponds to toxic waste on a biochemical level. A toxic system explains the many “side” effects of this “therapy,” which include nausea, hair loss, diarrhea, memory loss, and scar tissue. But another “side” effect of this “therapy” is either a recurrence of the original cancer, or the formation of other types of cancers! It’s common knowledge that radiation exposure—whether due to radioactive fallout from nuclear bombs, or meltdowns from nuclear power plants—increases the occurrence of cancers in people living near the source and even farther away. To use the radioactive materials acknowledged to cause cancer, as cancer therapy, makes no sense!

Chemo Causes Cancer Cells to Grow

In Greek, the word metastasis means “removal from one place to another.” Cancers often metastasize. What conventional medicine considers “primary” tumors can acquire greater motility and invasiveness, spreading to distant locations in the body via the bloodstream, lymphatic vessels, and membranes. For example, cancer first manifesting in the lung might spread to the liver, flooding the liver with cancerous lung cells. Metastasization often occurs after the subject has received toxic chemo. Thanks to new, highly publicized research, conventional medicine can no longer presume that this is a coincidence. New York City Albert Einstein College of Medicine researchers and colleagues have discovered that although chemo might initially decrease the number of breast cancer cells in a subject, ultimately its use is counterproductive because it triggers an environment favorable to the growth of tumors. Chemo actively interferes with the body’s ability to repair itself and opens more “doorways” on blood vessels—thus encouraging the cancerous cells to not only grow back and increase in number, but also aggressively migrate through the circulatory system.

—summarized from “Neoadjuvant chemotherapy induces breast cancer metastasis through a TMEM-mediated mechanism,” Science Translational Medicine Volume 9, Issue 397 July 5, 2017

- Nenah Sylver, The Rife Handbook of Frequency Therapy and Holistic Health, an integrated approach for cancer and other diseases (2011), p.674-675

The use of PEMF therapy in oncology is still limited. The first study utilizing PEMF therapy was conducted by Barbault and coworkers who hypothesized that a combination of specific frequencies, defined tumor-specific frequencies, may display therapeutic effectiveness for localized treatment of tumors. They identified a total of 1524 tumor-specific frequencies, ranging from 0.1 to 114 kHz, consisting in the measurement of variations in skin electrical resistance, pulse amplitude, and blood pressure in 163 patients affected by different types of cancer including brain tumors, colorectal cancer, HCC carcinoma, pancreatic, colorectal, ovarian, breast, prostate, lung, thyroid, and bladder cancer and exposed to the radiofrequency system.

Self-administered PEMF therapy for 60 min, three times a day, for an average of 278.4 months was offered to only 28 patients with advanced cancer (breast cancer [n = 7], ovarian cancer [n = 5], pancreatic cancer [n = 3], colorectal cancer [n = 2], prostate cancer [n = 2], glioblastoma multiforme [n = 1], HCC carcinoma [n = 1], mesothelioma [n = 1], neuroendocrine tumor [n = 1], non-small-cell lung cancer [n = 1], oligodendroglioma [n = 1], small-cell lung cancer [n = 1], sarcoma [n = 1] and thyroid tumor [n = 1]). None of the patients who received PEMF therapy reported any side effects; four patients presented stable disease for 3 years (thyroid cancer with biopsy-proven lung metastases), 6 months (mesothelioma metastatic to the abdomen), 5 months (non-small-cell lung cancer), and 4 months (pancreatic cancer with biopsyproven liver metastases), respectively.

PEMF therapy has also been employed for the treatment of HCC. Therapies for this disease are needed, especially for patients at an advanced disease stage who cannot tolerate chemotherapy or intrahepatic interventions because of impaired liver function. The feasibility of PEMF therapy for treatment of HCC has also been investigated in a single-group, open-label, phase I/II clinical study [102]. Forty-one patients with advanced HCC received very low levels of PEMFs modulated at HCC specific frequencies (100 Hz–21 kHz) and received threedaily 60 min outpatient treatments. No adverse reactions were observed during PEMF treatment. Five patients reported complete disappearance and two patients reported decrease in pain shortly after beginning of treatment. Four patients showed a partial response to treatment, while 16 patients (39%) had stable disease for more than 12 weeks. This study shows that PEMF therapy provides a safe and well-tolerated treatment, as well as evidence of antineoplastic effects in patients with HCC.

In summary, encouraging findings warrant randomized clinical studies to determine the effectiveness of amplitudemodulated PEMF therapy that can delay cancer progression and increase overall survival in patients. The increased knowledge of tumor-specific frequencies and the preliminary evidence that additional tumor-specific frequencies may yield a therapeutic benefit provide a strong rationale for the novel concept that administration of a large number of these frequencies may result in successful long-term disease management.

(Source : 6/12 OnlineLibraryWiley)

In Vitro Studies

PEMF therapy has been extensively studied in vitro using various human cancer cell lines, such as pheochromocytoma-derived (PC12), breast cancer (e.g., MCF7, MDA-MB-231 and T47D), and colon cancer (SW480 and HCT-116) [41–45]. These studies have shown that PEMF therapy may exert proliferative inhibition and mitotic spindle disruption [18, 40], block the development of neovascularization required for tumor supply [46–48] and exacerbate an inherent or induced genetic instability by reducing the stringency of the late-cycle (G2) checkpoint [49]. While chemotherapy is not specific to cancer cells and targets all rapidly dividing cells [50–52], PEMFs exert selective cytotoxic effect on neoplastic cells [15, 40, 53–55] making this therapy a highly promising strategy. In the next subparagraphs, we will review studies employing PEMF therapy in different cell lines as a model to study specific types of cancer (Table 1).

(Source : 2/12 OnlineWileyLibrary)

Numerous studies support the development of new treatments in oncology to be added to the traditional protocols to increase the effectiveness of available treatments, reducing side effect profile, and the patients’ quality of life [15–18]. Such resources include traditional Chinese medicine, Ayurvedic medicine, homeopathy, and naturopathy [19]. While complementary and alternative medicine (CAM) is not generally considered part of conventional medicine, it has been widely used in the oncology field as an add-on therapy to control patients’ symptoms and improve their quality of life [20–26]. The beginning of the 20th century saw the first therapeutic applications of CAM therapies for cancer treatment; these therapies include acupuncture, chromotherapy, therapeutic touch (reiki), and pulsed electromagnetic field (PEMF) therapy [4, 15, 27–30].

In this review, we have focused on PEMF therapy, a noninvasive technique characterized by electromagnetic fields inducing microcurrents to the entire body or locally to target specific body tissues. Exposure to PEMFs in the 0–300 Hz range is a therapeutic tool extensively used for the treatment of several pathologies including osteoarthritis, Parkinson’s disease, postsurgical pain and edema, treatment of chronic wounds, and facilitation of vasodilatation and angiogenesis producing direct stimulation to excitable cells including nerve and muscle cells [31–34]. Stimulation with sufficient intensity and duration induces a current across targeted cell membranes, activating nerve cells or muscles to propagate action potentials [35–37]. Indeed, PEMF therapy can be used as an adjuvant treatment to chemotherapy and radiotherapy with the aim of reducing their dosage, mitigating any harmful secondary side effects, and enhancing patient’s prognosis [15, 35, 38–40].

(Source : 2/12 OnlineLibraryWiley)

Electroporation (i.e., reversible electrical breakdown) has been used for biomedicine such as electroporation therapy, transdermal drug delivery, cellular drug carrier systems, and gene transfer therapy. However, little research on the biological effect of irreversible electrical breakdown has been published.

In this paper, the killing and inhibiting effects of pulsed electric field, whose rising edge is 100 ns level (we call it steep pulsed electric field, SPEF), to target cancer cell and solid tumor were successfully observed.

The SPEF consists of two parts: the rising process containing ample high-frequency components, and the falling process containing lots of low-frequency components. Cell exposed to the pulse presented multiple changes: destructed membrane, swollen nucleus, disintegrated karyotheca, and cavitated, swollen mitochondria in histological and ultrastructure observations. SPEF blocked cell transition from G0/G1 phase to S+G2/M phase in flow cytometry analysis, and tumor growth retardation was observed in tumor-bearing mice. These experimental results show SPEF have a certain function to generate irreversible electrical breakdown in tumor cells, and might provide a new promising therapeutic approach for tumor treatment.

Cancer causes approximately seven million deaths annually according to the statistics of the World Health Organization. Today, oncologists often face a dilemma when choosing these conventional methods: surgery, radiation and systematic chemotherapy, or radio-frequency ablation. Because of their inability to suit all the patients and avoid side effects, it is urgent and meaningful to seek new approaches for such patients.

(Source : IEEEXplore)

Effects of extremely low-frequency pulsed electromagnetic fields (ELF-PEMFs) on glioblastoma cells (U87) :

The impact of extremely low-frequency pulsed electromagnetic fields (ELF-PEMFs) at various frequencies and amplitudes was investigated on cell cycle, apoptosis and viability of the Glioblastoma Multiforme (GBM) cell line (U87), in vitro. The GBM is a malignant brain tumor with high mortality in humans and poorly responsive to the most common type of cancer treatments, such as surgery, chemotherapy and radiation therapy.

The data suggest that the proliferation and apoptosis of human GBM are influenced by exposure to ELF-PEMFs in different time-dependent frequencies and amplitudes. The fact that some of the ELF-PEMFs frequencies and amplitudes favor U87 cells proliferation indicates precaution for the use of medical devices related to the MFs on cancer patients. On the other hand, some other ELF-PEMFs frequencies and intensities arresting U87 cells growth could open the way to develop novel therapeutic approaches.

The authors wish to appreciate the financial support of the Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, 76175-113 Kerman, Iran. 

(Source : Tandonfline)

Abstract

Cancer is one of the major diseases that endanger human health. Current treatment options have low patient tolerance, poor prognosis, and strong side effects. Pulsed electromagnetic therapy can selectively kill cancer cells by taking advantage of their own electromagnetic sensitivity specificity. Pulsed electric fields (PEFs), pulsed electromagnetic fields (PEMFs), and cold atmospheric plasma (CAP) are three main means that have promising application in cancer therapy. Pulsed electromagnetic therapy showed significant anticancer ability in vitro and in vivo. In this paper, we summarize the basic principles, methods, and state of art research of PEFs, PEMFs, and PEMFs for cancer therapy. Based on cancer pro-oxidation therapy, we propose a combination therapy of electromagnetic field-enhanced CAP for cancer therapy.

Inhibition of tumor cell or tissue proliferation

Zeng et al. found that tumor growth in mice was inhibited by the effect of 0.6–2.0 T magnetic field. The metabolism, mitosis, and high-speed anomalous growth of tumor cells were inhibited in the irradiated group. de Seze et al. applied a magnetic field with an intensity of 0.12 T and a frequency of 0.8 Hz to natural killer cells and observed a significant increase in the proliferation of natural killer cells within 1 week compared to the previous one, indicating that a magnetic field of this intensity can improve the body's ability to suppress cancer. Tuffet and de Seze found that 0.18 T, 0.8 Hz unipolar square wave pulsed magnetic field reduced the proliferation of isolated cervical cancer cells by 15%. Under the same parameters, pulsed magnetic field treatment for 8 h a day, 5 days a week, significantly prolonged the survival of tumor-bearing mice. The effect of the nonuniform field was better than that of the uniform field, with the pulsed magnetic field producing the highest induced current at the edge of the subject and the lowest induced current at the center. Cameron et al. used a pulsed magnetic field (15 mT, 120 pulses/s) to treat human breast cancer cells (MDA-MB-231) transplanted into mice. It was found that the growth of breast cancer was effectively inhibited in the irradiated mice compared to the nonmagnetic field irradiated mice, while the tumors in the original lung metastases in the mice were significantly reduced, with slow tumor growth and no significant harmful side effects. Filipovic et al. investigated the effects of a 50 Hz magnetic field on different types of cancer cells. Breast cancer cells MDA-MB-231, colorectal cancer cells SW-480, and HCT-116 were irradiated under a specific magnetic field for 24–72 h, and the results showed that the growth of all three types of cancer cells was significantly inhibited. Williams et al.61 further found that 10 min of daily 10, 15 or 20 mT pulsed magnetic field irradiation (120 pulses/s) significantly slowed tumor growth and reduced vascularization relative to mice not exposed to magnetic fields.

(Source : OnlineLibrayWiley)

Le professeur Pautrizel a engagé ses travaux en prenant des modèles expérimentaux qui sont des animaux : des rats. Avec l'appareil utilisé pour des animaux de petites tailles, il obtint des résultats très encourageants pour traiter le cancer humain. Ses travaux furent réalisés à la demande du professeur Courrier, président de l'Académie de médecine et, à ce propos, le professeur Robert Courrier conseilla de continuer les expériences sur le cancer, ce que fit M. Pautrizel.

Il est intéressant de s'arrêter sur la thèse soutenue par Éric Périsse, pour son doctorat en médecine à l'université de Bordeaux, sous la présidence du professeur Courty, et j'ai pu assister à des guérisons étonnantes à l'aide de l'appareil d'Antoine Priore. C'est appareil émet une impulsion d'ondes dont la fréquence varie en puissance. 

L'expérimentation fut réalisée de la manière suivante : on greffa sur des rats domestiques une tumeur K sous-cutanée ; on irradia la tumeur par ce champ électromagnétique pulsé. On obtint alors une disparition de la tumeur ainsi que la fonte des métastases et des ganglions.

1. Pas d'effets secondaires suite à ce traitement.
2. Pas de récidive trois mois après l'arrèt du traitement.

Nous retenons que ces résultats étonnants sont fonctions de trois facteurs qui sont incontournables pour l'efficacité des OEMP :

1. l'intensité du champ magnétique Tesla ;
2. la durée du temps d'exposition ;
3. l'ancienneté de la tumeur.

L'appareil d'Antoine Priore émettait une intensité de l'ordre de 30 millitesla sur un temps d'exposition de vingt à quarante minutes journalières.

Le traitement commença dix jours après la greffe, et on obtint 100% de stérilisation de la tumeur et des métastases ; le traitement dura vingt-cinq à trente-sept jours ; treize cas furent exposés dans cette thèse, en fonction des variations des trois facteurs précédents.

Conclusion : les résultats encourageants obtenus avec cette méthode furent utilisés dans le traitement de nombreux cancers humains, quelques-uns furent guéris et d'autres améliorés. Ce qui est certain, c'est la stimulation bénéfiques des OEMP dans le processus immunitaires de l'organisme.

On constate que bien avant que l'électricité ne devienne une science de la physique, elle a une longue histoire médicale. De nos jours, elle reste indispensable en médecine. Le pacemaker en est l'exemple le plus réel ; il démontrer le lien entre électricité et vie. La porte est grande ouverte à l'électromagnétisme.

L'avenir de l'utilisation des ondes électromagnétiques est de plus en plus assuré dans les milieux hospitalier.

Sur Internet, le blog santé du docteur Flaysakier précise que : « c'est une voie thérapeutique de plus en plus explorée. Les ondes électromagnétiques stimulent les zones motrices du cerveau. Après les bons résultats sur les douleurs chronniques et fibromyalgiques, c'est la dépression qui pourrait être améliorée ».

- Dr Georges Dussert, Les ondes électromagnétiques pour nous soigner (2013), p.77-76